Induction of cyclooxygenase expression and enhancement of malignant cell transformation by 2,3,7,8-tetrachlorodibenzo-p-dioxin

Carcinogenesis

Volumn 21, Issue 1, 2000, Pages 15-21

  Wölfle, Detlef ^a,c   Marotzki, Stefan ^a   Dartsch, Dorothee ^a   Schäfer, Wolfgang ^b   Marquardt, Hans ^a  

^a University Medical School Hamburg Eppendorf   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Fed Inst Hlth Protect C   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; 6 OXOPROSTAGLANDIN F1 ALPHA; CAFFEIC ACID; HYDROCORTISONE; INDOMETACIN; LIPOXYGENASE; MESSENGER RNA; METHYLNITRONITROSOGUANIDINE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NORDIHYDROGUAIARETIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FIBROBLAST; IMMUNOBLOTTING; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

EID: 0343340441     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.1.15     Document Type: Article

References (70)

1. Pitot, H.C., Goldsworthy, T. Campell, H.A. and Poland, A. (1980) Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res., 40, 3616-3620.
2. Bertazzi, P.A., Zocchetti, C., Guercilena, S., Consonni, D., Tironi, A., Landi, M.T. and Pesatori, A.C. (1997) Dioxin exposure and cancer risk: a 15-year mortality study after the 'Seveso accident'. Epidemiology, 8, 646-652.
3. Gaido, K.W. and Maness, S.C. (1995) Post-transcriptional stabilization of urokinase plasminogen activator mRNA by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a human keratinocyte cell line. Toxicol. Appl. Pharmacol., 133, 34-42.
4. Enan, E. and Matsumura, F. (1996) Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem. Pharmacol., 52, 1599-1612.
5. Wölfle, D., Schmutte, C. and Marquardt, H. (1993) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on protein kinase C and inositol phosphate metabolism in primary cultures of rat hepatocytes. Carcinogenesis, 14, 2283-2287.
6. Puga, A., Nebert, D.W. and Carrier, F. (1992) Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol. 11, 269-281.
7. Wolfle, D. and Marquardt, H. (1996) Antioxidants inhibit the enhancement of malignant cell transformation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis, 17, 1273-1278.
8. Smart, R.C., Huang, M.-T., Han, Z.T., Kaplan, M.C., Focella, A. and Conney, A.H. (1987) Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of ornithine decarboxylase activity. DNA synthesis, and tumor promotion in mouse skin by ascorbic acid and ascorbyl palmitate. Cancer Res., 47, 6633-6638.
9. Müller-Decker, K., Scholz, K., Marks, F. and Fürstenberger, G. (1995) Differential expression of prostaglandin H synthase isoenzymes during multistage carcinogenesis in mouse epidermis. Mol. Carcinogen., 12, 31-41.
10. Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W.W., Fong, H.H.S., Farnsworth, N.R., Kinghorn, A.D., Metha, R.G., Moon, R.C. and Pezzuto, J.M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220.
11. Giovannucci, E., Egan, K.M., Hunter, D.J., Stampfer, M.J., Colditz, G.A., Willet, W.C. and Speizer, F.E. (1995) Aspinn and the risk of colorectal cancer in women. N. Engl. J. Med., 333, 609-614.
12. Labayle, D., Fischer, D. and Vielh, P. (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101, 635-639.
13. Hirota, C., Iida, M., Aoyagi, K., Matsumoto, T., Tada, S., Yao, T. and Fujishima, M. (1996) Effect of indomethacin suppositories on rectal polyposis in patients with familial adenomatous polyposis. Cancer, 78, 1660-1665.
14. Lupulescu, A. (1996) Prostaglandins, their inhibitors and cancer. Prostaglandins Leukot. Essent. Fatty Acids, 54, 83-94.
15. Sakata, J., Hasegawa, R., Johansson, S.L., Zenser, T.V. and Cohen, S.M. (1986) Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats. Cancer Res., 46, 3903-3906.
16. Carter, C.A., Ip,M.M. and Ip,C. (1989) A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acid. Carcinogenesis, 10, 1369-1374.
17. Reddy, B.S., Maruyama, H. and Kelloff, G. (1987) Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res., 47, 5340-5346.
18. 2 in ornithine decarboxyla.se induction by a tumor-promoting agent, 7-bromomethylbenz[a]anthracene, in mouse epidermis. Carcinogenesis, 13, 905-906.
19. 2 inhibitor. Gann, 73, 841-843.
20. Earashi, M., Noguchi, M., Kinoshita, K. and Tanaka, M. (1995) Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line. Oncology, 52, 150-155.
21. Parrett, M.L., Harris, R.E., Joarder, F.S., Ross, M.S., Clausen, K.P. and Robertson, F.M. (1997) Cyclooxygenase-2 gene expression in human breast cancer. Int. J. Oncol. 10, 503-507.
22. Buckmann, S.J., Gresham, A., Hale, P., Hruza, G., Anast, J., Masferrer, J. and Pentland, A.P. (1998) Cox-2 expression is induced by UVB exposure in human skin: Implication for the development of skin cancer. Carcinogenesis, 19, 723-729.
23. Marnett, L.J. (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52, 5575-5589.
24. Kraemer, S.A., Arthur, K.A., Denison, M.S., Smith, W.L. and Dewitt, D.L. (1996) Regulation of prostaglandin endoperoxide H synthase-2 expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch. Biochem. Biophys., 330, 319-328.
25. Puga, A., Hoffer, A., Zhou, S., Bohm, J.M., Leikauf, G.D. and Shertzer, H.G. (1997) Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem. Pharmacol., 54, 1287-1296.
26. Vogel, C., Schuhmacher, U.S., Degen, G.H., Bolt, H.M., Pineau, T. and Abel, J. (1998) Modulation of prostaglandin H synthase-2 mRNA expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice. Arch. Biochem. Biophys., 351, 265-271.
27. Levy, G.N. (1997) Prostanglandin H synthases, non-steroidal anti-inflammatory drugs, and colon cancer. FASEB J., 11, 234-247.
28. Marquardt, H., Philips, F.S. and Sternberg, S.S. (1976) Tumorigenicity in vivo and induction of malignant transformation and mutagenicity in cell cultures by adriamycin and daunomycin. Cancer Res., 36, 2065-2069.
29. Sanchez, J.H., Abernethy, D.L. and Boreiko, C.J. (1986) Reversible expression of morphological transformation in C3H 10T1/2 mouse embryo cultures exposed to 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis, 7, 1793-1796.
30. Schafer, W.R., Zahradnik, H.P. Arbogast, E., Wetzka, B., Werner, K. and Breckwoldt, M. (1996) Arachidonate metabolism in human placenta, fetal membranes, decidua and myometrium: lipoxygenase and cytochrome P450 metabolites as main products in HPLC profiles. Placenta, 17, 231-238.
31. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
32. Marotzki, S. (1997) Molekuarbiologische und zellbiologische mechanismen der tumorpromotion durch polychlorierte aromatische kohlenwasserstoffe am beispiel von 2,3,7,8-tetrachlordibenzo-p-dioxin. Thesis, Medical School Hamburg, Germany.
33. Semba, M. and Inui, N. (1990) Inhibition of 12-O-tetradecanoylphorbol-13-acetate-enhanced transformation in vitro by inhibitors of phospholipid metabolism. Toxicol. Lett., 51, 1-6.
34. Evett, G.E., Xie, W., Chipman, J.G., Robertson, D.L. and Simmons, D.L. (1993) Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: regulation by dexamethasone, mitogens and oncogenes. Arch. Biochem. Biophys., 306, 169-177.
35. Fürstenberger, G., Gross, M. and Marks, F. (1989) Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion). Carcinogenesis, 10, 91-96.
36. Shibata, M.A., Hasegawa, R., Shirai, T., Takesada, Y. and Fukushima, S. (1993) Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model. Int. J. Cancer, 55, 1011-1017.
37. Reeve, V.E., Matheson, M.J., Bosnic, M. and Boehm-Willox, C. (1995) The protective effect of indomethacin on photocarcinogenesis in hairless mice. Cancer Lett., 95, 213-219.
38. 2 in ornithine decarboxylase induction by a tumor-promoting agent, 7-bromomethylbenz[a]anthracene, in mouse epidermis. Carcinogenesis, 13, 905-906.
39. Herschman, H.R. (1996) Prostaglandin synthase 2. Biochim. Biophys. Acta, 1299, 125-140.
40. Mitchell, J.A., Larkin, S. and Williams, T.J. (1995) Cyclooxygenase-2: Regulation and relevance in inflammation. Biochem. Pharmacol., 50, 1535-1542.
41. Xie, W. and Herschman, H.R. (1996) Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J. Biol. Chem., 271, 31742-31748.
42. Angermann-Stewart, J.A., Eling, T.E. and Glasgow, W.C. (1995) Prostandin H synthase-2 is induced in Syrian hamster embryo cells in response to basic fibroblast growth factor. Arch. Biochem. Biophys., 318, 378-386.
43. Raz, A., Wyche, A., Siegel, N. and Needleman, P. (1988) Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J. Biol. Chem., 263, 3022-3028.
44. Funk, C.D. and Fitzgerald, G.A. (1991) Eicosanoid forming enzyme mRNA in human tissues. Analysis by quantitative polymerase chain reaction. J. Biol. Chem., 266, 12508-12513.
45. Ledwith, B.J., Pauley, C.J., Wagner, L.K., Rokos, C.L., Alberts, D.W. and Manam, S. (1997) Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristale-typ tumor promoters in immortalized mouse liver cells. J. Biol. Chem., 272, 3707-3714.
46. Maldve, R.E. and Fischer, S.M. (1996) Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes. Mol. Carcinogen., 17, 207-216.
47. Sano, H., Kawahito, Y., Wilder, R.L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla,T. (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789.
48. Ristimäki, A., Honkanen, N., Jänkälä, H., Sipponen, P. and Härkönen, M. (1997) Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res., 57, 1276-1280.
49. Subbaramaiah, K., Telang, N., Ramonetti, J.T., Araki, R., DeVito, B., Weksler, B.B. and Dannenberg, A.J. (1996) Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res., 56, 4424-4429.
50. Wallace, J.L., Bak, A., McKnight, W., Asfaha, S., Sharkey, K.A. and MacNaughton, W.K. (1998) Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology, 115, 101-109.
51. Reddy, B.S., Rao, C.V. and Seibert, K. (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56, 4566-4569.
52. Nebert, D.W., Puga, A. and Vasiliou, V. (1993) Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. NY Acad. Sci., 685, 624-640.
53. Marotzki, S., Wölfle, D. and Marquardt, H. (1997) Enhanced transcription of cyclooxygenase is associated with the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced promotion of malignant transformation of mouse fibroblasts in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol., 355 (suppl.), R152.
54. Chiu, C.-H., McEntee, M.F. and Whelan, J. (1997) Sulindac causes rapid regression of preexisting tumors in Minl+ mice independent of prostaglandin biosynthesis. Cancer Res., 57, 4267-4273.
55. Kantor, H.S. and Hampton, M. (1978) Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase. Nature, 276, 841-842.
56. Van Lieshout, E.M.M., Tiemessen, D.M., Peters, W.H.M. and Jansen, J.B.M.J. (1997) Effects of nonsteroidal anti-inflammmatory drugs on glutathione S-transferases of the rat digestive tract. Carcinogenesis, 18, 485-490.
57. Samaha, H.S., Kelloff, G.J., Steele, V., Rao, C. and Reddy, B.S. (1997) Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res., 57, 1301-1305.
58. Leibold, E. and Schwarz, L.R. (1993) Inhibition of intercellular communication in rat hepatocytes by phenobarbital 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) and γ-hexachlorocyclohexane (lindane): modulation by antioxidants and inhibitors of cyclooxygenase. Carcinogenesis, 14, 2377-2382.
59. Krieg, P., Kinzig, A., Ress-Löschke, M., Vogel, S., Vanlandingham, B., Stephan, M., Lehmann, W.-D., Marks, F. and Fürstenberger, G. (1995) 12-Lipoxygenase isoenzymes in mouse skin tumor development. Mol. Carcinogen., 14, 118-129.
60. Fürstenberger, G., Csuk-Glänzer, B.I., Marks, F. and Keppler, D. (1994) Phorbol ester-induced leukotriene biosynthesis and tumor promotion in mouse epidermis. Carcinogenesis, 15, 2823-2827.
61. Fischer, S.M, Baldwin, J.K., Jasheway, D.W., Patrick, K.E. and Cameron, G.S. (1988) Phorbol ester induction of 8-lipoxygenase in inbred SENCAR (SSIN) but not C57BL/6J mice correlated with hyperplasia, edema, and oxidant generation but not ornithine decarboxylase induction. Cancer Res., 48, 658-664.
62. Jiang, H., Yamamoto, S. and Kato, R. (1994) Inhibition of two-stage skin Carcinogenesis as well as complete skin Carcinogenesis by oral administration of TMK688, a potent lipoxygenase inhibitor. Carcinogenesis, 15, 807-812.
63. Rao, C.V., Desai, D., Simi, B., Kulkarni, N., Amin, S. and Reddy, B.S. (1993) Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res., 53, 4182-4188.
64. Denda, A., Tang, Q., Endoh, T., Tsujiuchi, T., Horiguchi, K., Noguchi, O., Mizumoto, Y., Nakae, D. and Konishi, Y. (1994) Prevention by acetylsalicylic acid of liver cirrhosis and Carcinogenesis as well as generations of 8-hydroxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in rats. Carcinogenesis, 15, 1279-1283.
65. 2-terminal kinase). Eur. J. Biochem., 244, 587-595.
66. Van der Vliet, A. and Bast, A. (1992) Effect of oxidative stress on receptors and signal transmission. Chem. Biol. Interact., 85, 95-116.
67. Rao, G.N., Glasgow, W.C., Eling, T.E. and Runge, M.S. (1996) Role of hydroperoxy-eicosatetraenoic acids in oxidative stress-induced activating protein 1 (AP-1) activity. J. Biol Chem., 271, 27760-27764.
68. Rao, C.V., Simi, B. and Reddy, B.S. (1993) Inhibition by dietary curcumin of azomethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and abberant crypt foci formation in the rat colon. Carcinogenesis, 14, 2219-2225.
69. Rao, K.V.N., Detrisac, C.J., Steele, V.E., Hawk, E.T., Kelloff, G.J. and McCormik, D.L. (1996) Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder. Carcinogenesis, 17, 1435-1438.
70. Pereira, M.A., Grubbs, C.J., Barnes, L.H., Li, H., Olson, G.R., Eto, I., Juliana, M., Whitaker, L.M., Kelloff, G.J., Steele, V.E. and Lubet, R.A. (1996) Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis, 17, 1305-1311.